| |
|
|
|
Dr. Ming-Daw Tsai
|
Distinguished Research Fellow
& Director
|
| |
Institute of Biological Chemistry, Academia Sinica
128, Academia Road Sec. 2, Nankang, Taipei 115, Taiwan
|
TEL: +886-2-2785-5696
ext. 1010
FAX: +886-2-2788-9759
mdtsai@gate.sinica.edu.tw
|
|
Ming-Daw Tsai's Website
The main research program of Tsai lab focuses on proteins involved in cell cycle progression that are closely related with cancer and virus infection. Our structure and function studies on INK, CDK4, and Chk2 proteins shed great light on the mechanisms underlying some cancer diseases, while our enzymological characterizations of human and viral polymerases empower us to further understand the DNA damage response and repair at DNA level. In addition, we investigate the signaling pathways involving protein-phosphoprotein interactions mediated by the FHA domain, in both human (e.g. Ki67) and yeast (e.g. Rad53 and Dun1). Another project focuses on the mechanism and biological function of histone demethylases, including yeast Rph1 and human RBP2.

|
- 1978
|
Ph.D, Biochemistry & Medicinal Chemistry, Purdue University
|
|
- 1972
|
B.S., Chemistry, National Taiwan University, Taipei
|

|
2008,08 - 2014,08
|
Director, Institute of Biological Chemistry, Academia Sinica
|
|
2006,10 - 2008,08
|
Acting Director, Institute of Biological Chemistry, Academia Sinica
|
|
2005 -
|
Director, Division of Functional Genomics, Genomics Research Center
|
|
2003 -
|
Director, National Research Program for Genomic Medicine Core Facility Office
|
|
1995 - 2003
|
Director, Chemistry/Biology Interface Training Program, OSU
|
|
1993 - 2007
|
Director, Office of Research Campus Chemical Instrument Center, The Ohio State University
|
|
1992 - 1992
|
Elected Fellow, American Association for the Advancement of Science (AAAS)
|
|
1992 - 1992
|
Distinguished Scholar Award, Ohio State University
|
|
1985 - 1990
|
Camille and Henry Dreyfus Teacher-Scholar
|
|
1985 - 1985
|
Faculty Research Award, Ohio State Chapter of Sigma Xi
|
|
1983 - 1985
|
Alfred P. Sloan Fellow
|
|
1981 -
|
Kimberly Professor of Chemistry and Professor of Biochemistry, The Ohio State University (starting as Assistant Professor)
|
 
|
E339…R416 salt bridge of nucleoprotein as a feasible target for influenza virus inhibitors.
|
|
Yu-Fang Shen, Yu-Hou Chen, Shao-Ying Chu, Meng-I Lin, Hua-Ting Hsu, Pei-Yu Wu, Chao-Jung Wu, Hui-Wen Liu, Fu-Yang Lin, Gialih Lin, Pang-Hung Hsu, An-Suei Yang, Yih-Shyun E. Cheng, Ying-Ta Wu, Chi-Huey Wong*, Ming-Daw Tsai*
Proceedings of the National Academy of Sciences of the United States of America (2011)
|
|
The ARID domain of the H3K4 demethylase RBP2 binds to a DNA CCGCCC motif.
|
|
Shengjiang Tu, Yu-Ching Teng, Chunhua Yuan, Ying-Ta Wu, Meng-Yu Chan, An-Ning Cheng, Po-Hsun Lin, Li-Jung Juan*, Ming-Daw Tsai*
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
|
|
Diphosphothreonine-specific interaction between an SQ/TQ cluster and an FHA domain in the Rad53-Dun1 kinase cascade.
|
|
H. Lee, C. Yuan, A. Hammet, A. Mahajan, S. W. Chen, M. R. Wu, M. I. Su, J. Heierhorst*, M. D. Tsai*
Mol. Cell (2008)
|
|
Structure and Function of the Phosphothreonine-Specific FHA Domain.
|
|
Anjali Mahajan, Chunhua Yuan, Hyun Lee, Eric S.-W. Chen, Pei-Yu Wu, Ming-Daw Tsai*
Science Signaling (2008)
|
|
Mechanistic comparison of high-fidelity and error-prone DNA polymerases and ligases involved in DNA repair.
|
|
Showalter AK, Lamarche BJ, Bakhtina M, Su MI, Tang KH, Tsai MD
Chemical reviews (2006)
|
|
Sequential Phosphorylation and Multisite Interactions Characterize Specific Target Recognition by the FHA Domain of Ki-67.
|
|
In-Ja L. Byeon, Hongyuan Li, Haiyan Song, Angela M. Gronenborn, and Ming-Daw Tsai
Nature Structural and Molecular Biology (2005)
|
|
Solution structure of a viral DNA polymerase X and evidence for a mutagenic function.
|
|
A. K. Showalter, I. J. Byeon, M. I. Su and M. D. Tsai
Nat Struct Biol (2001)
|
|
Interfacial enzymology: the secreted phospholipase A(2)-paradigm.
|
|
O. G. Berg, M. H. Gelb, M. D. Tsai and M. K. Jain
Chem Rev (2001)
|
|
Tumor suppressor p16INK4A: determination of solution structure and analyses of its interaction with cyclin-dependent kinase 4.
|
|
I. J. Byeon, J. Li, K. Ericson, T. L. Selby, A. Tevelev, H. J. Kim, P. O'Maille and M. D. Tsai
Mol Cell (1998)
|
|
|
|